Patents
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
12/2002
12/25/2002CN1387399A Methods of producing target molecule in transgenic animal and purification of target molecule
12/25/2002CN1386859A Coding sequence of arisaema agglutinant protein and its application
12/25/2002CN1386858A 3 novel humanized tumor cell reproduction and tumor transfer suppressor genes
12/25/2002CN1386762A Polypeptide-human macroprotein-51.37 and polynucleotide for coding it
12/25/2002CN1386761A Polypeptide-human reverse transcription associated protein-14.08 and polynucleotide for coding it
12/25/2002CN1386760A Polypeptide-olfactory receptor-10.78 and polynucleotide for coding it
12/25/2002CN1386759A Polypeptide-elastatinal-43.12 and polynucleotide for coding it
12/25/2002CN1386758A Polypeptide-human reverse transcription associated protein-15.07 and polynucleotide for coding it
12/25/2002CN1386757A Polypeptide-leukemia associated protein 29.81 and polynucleotide for coding it
12/25/2002CN1386756A Polypeptide-polypeptide chain surface receptor-38.28 and polynucleotide for coding it
12/25/2002CN1386755A Polypeptide-glucoprotein-11.22 and polynucleotide for coding it
12/25/2002CN1386753A Recombinant human endothelial growth arrestin with activity of inhibiting endothelial cell growth
12/25/2002CN1386752A Gene-recombinant anticoaglant protein
12/25/2002CN1386751A Polypeptide-Pre-mRNA splicing factor-59.40 and polynucleotide for coding it
12/25/2002CN1386750A Process for preparing platelet factor 4 as genetically engineered medicine
12/25/2002CN1386749A Polypeptide-cotransporter-10.34 and polynucleotide for coding it
12/25/2002CN1386748A Polypeptide-ribosomal L3 protein-9.68 and polynucleotide for coding it
12/25/2002CN1386747A Polypeptide-histone H4-10.01 and polynucleotide for coding it
12/25/2002CN1386746A Polypeptide-thermal shock protein-10.67 and polynucleotide for coding it
12/25/2002CN1386745A Process for extracting thallus from waste liquid of gourmet powder
12/25/2002CN1097213C Luminous hand of electroluminescence
12/25/2002CN1097058C Platelet growth accelerator
12/24/2002US6498244 Adeno-associated virus capsid immunologic determinants
12/24/2002US6498243 Epimorphin antagonist and process for producing it
12/24/2002US6498235 Testis specific glycoprotein zpep10
12/24/2002US6498234 Compounds
12/24/2002US6498233 Nucleic acid transfer system
12/24/2002US6498142 Osteogenic protein-1 (op-1) and other members of the op-1 subfamily of the tgf-.beta. superfamily of growth factors
12/24/2002US6498141 Method and apparatus for preparing an acellular red blood cell substitute
12/24/2002US6498022 Isolated nucleic acid molecules encoding human carbonate transporter proteins, and uses thereof
12/24/2002US6498021 Isolated nucleic acid molecules coding for tumor rejection antigen precursor MAGE-8 and uses thereof
12/24/2002US6498020 Fusion proteins comprising coiled-coil structures derived of bovine IF1 ATPase inhibitor protein
12/24/2002US6498015 Genetic engineering; production of macrophage derived chemokine; drug screening for antiinflammatory agents
12/24/2002US6498014 Detecting peta-3 antigen for cancer diagnosis
12/24/2002US6498011 Method for transformation of animal cells
12/24/2002US6497884 Viable chimeric recombinant flavivirus comprising region of nucleic acid encoding premembrane and envelope structural proteins of langat virus linked to region of nucleic acid encoding non-structural proteins of dengue type 4 virus
12/24/2002US6497883 Porcine circovirus recombinant poxvirus vaccine
12/24/2002US6497882 Virus comprising foreign dna inserted into swinepox virus genome within specified region, which is capable of being expressed in host cell into which virus is introduced
12/24/2002US6497880 Heat shock genes and proteins from Neisseria meningitidis, Candida glabrata and Aspergillus fumigatus
12/24/2002US6497879 Composition which comprises isolated mage-10 tumor rejection antigen precursor which is encoded by nucleic acid having specified nucleotide sequence
12/24/2002US6497876 Method of stimulating an immune response with activated dendritic cells
12/24/2002US6497874 Modified filamentous phage which retains ability to bind and infect helicobacter pylori
12/24/2002US6497873 Rhabdovirus comprising heterologous fusion protein which facilitates fusion of rhabdovirus to target cell membrane, heterologous g stem polypeptide, rhabdovirus n, p and l proteins, deletion of nucleotide sequence encoding g protein
12/24/2002US6497872 Neural transplantation using proliferated multipotent neural stem cells and their progeny
12/24/2002US6497871 Polypeptide having anti-viral and anti-proliferative activity
12/24/2002US6497870 Inhibiting interferon-gamma production induced by interleukin-18 in human suffering from viral infection by administering polypeptide having specified amino acid sequence, not interleukin-1 beta-induced inflammation
12/24/2002US6497869 Having a ph of 5.0 to 8.0, and a salt comprising sulfate ions; treatment of shipping fever, bovine mastitis
12/24/2002CA2147863C Determination of peptide motifs on mhc molecules
12/24/2002CA2145969C Transcription factor aprf
12/24/2002CA2087261C Purification directed cloning of peptides
12/24/2002CA2086264C Surface complexed lymphotoxin
12/24/2002CA2075878C Cyclic peptides and use thereof
12/24/2002CA2070182C Chimeric immunoglobulin for cd4 receptors
12/24/2002CA2065404C Assays and reagents for amyloid deposition
12/19/2002WO2002101629A1 Solution structure of il-13 and uses thereof
12/19/2002WO2002101232A2 Bace interacting proteins
12/19/2002WO2002101080A2 Isolated human secreted proteins, nucleic acid molecules encoding human secreted proteins, and uses thereof
12/19/2002WO2002101079A2 Anti-apoptosis genes and methods of use thereof
12/19/2002WO2002101075A2 Novel genes, compositions, kits, and methods for identification, assessment, prevention, and therapy of cervical cancer
12/19/2002WO2002101074A2 Nucleic acid constructs useful for glucose regulated production of human insulin in somatic cell lines
12/19/2002WO2002101072A2 Letm1: modulators of cellular proliferation
12/19/2002WO2002101071A2 Cd43:modulators of mast cell degranulation
12/19/2002WO2002101069A2 Ns4 nucleic acids and polypeptides and methods of use for the treatment of body weight disorders
12/19/2002WO2002101060A1 Processes and vectors for producing transgenic plants
12/19/2002WO2002101059A2 Transgenic plants synthesising high amylose starch
12/19/2002WO2002101058A1 Novel promoter
12/19/2002WO2002101051A2 Genes and proteins for the biosynthesis of anthramycin
12/19/2002WO2002101049A2 Interleukin-18 mutants, their production and use
12/19/2002WO2002101048A2 NEW POLYNUCLEOTIDES AND POLYPEPTIDES OF THE IFNα-7 GENE
12/19/2002WO2002101047A1 Method of identifying compounds that modulate epo primary response gene 1, eprg1, activities
12/19/2002WO2002101045A2 Vanilloid receptor-related nucleic acids and polypeptides
12/19/2002WO2002101044A2 Brain expressed gene and protein associated with bipolar disorder
12/19/2002WO2002101043A2 Regulation of human ta4 receptor
12/19/2002WO2002101040A1 Human-type anti-blood coagulation factor viii antibody
12/19/2002WO2002101039A1 Method of testing drug for treating or preventing diseases such as hyperlipemia
12/19/2002WO2002101035A1 Novel potential-dependent cation channel protein
12/19/2002WO2002101034A1 Leptin-induced gene
12/19/2002WO2002101031A1 Cyp450-specific dna probes and primers, and biological applications thereof
12/19/2002WO2002101026A2 Methods for binding acma-type protein anchor fusions to cell-wall material of micro-organisms
12/19/2002WO2002101021A2 Purification of human serum albumin
12/19/2002WO2002101020A2 A synthetic dna encoding an orange seapen-derived green fluorescent protein with codon preference of mammalian expression systems and biosensors
12/19/2002WO2002101016A2 A gene family encoding membrane steroid receptors
12/19/2002WO2002101009A2 Structural and cytoskeleton-associated proteins
12/19/2002WO2002101008A2 Intracellular signaling molecules
12/19/2002WO2002101005A2 A g-protein coupled receptor and uses therefor
12/19/2002WO2002101002A2 Identification of snps the hgv-v gene
12/19/2002WO2002100901A2 Determination of bone-sialoprotein in bodily fluids for oncological problems
12/19/2002WO2002100899A2 Medicament for treating tumours and their metastases using a binding molecule against bone-sialoprotein
12/19/2002WO2002100898A2 Polypeptide having an activity to support proliferation or survival of hematopoietic stem cell and hematopoietic progenitor cell, and dna coding for the same
12/19/2002WO2002100895A2 Antimicrobially active peptide
12/19/2002WO2002100894A2 Dna encoding a mutant peroxisome proliferator-activated receptor gamma coactivator-1 (pgc-1), detection methods and test kits therefor
12/19/2002WO2002100893A1 A novel polypeptide - granin-9.35 and a polynucleotide encoding the same
12/19/2002WO2002100891A2 Proteins derived from non-typable haemophilus influenzae (nthi) strain
12/19/2002WO2002100890A2 Respiratory syncytial virus
12/19/2002WO2002100889A1 Novel epitope of human papilloma virus e7 antigen and cd4-positive t cells activated by the epitope
12/19/2002WO2002100888A1 Somatostatin-dopamine chimeric analogs
12/19/2002WO2002100887A2 Method for making insulin precursors and insulin precursor analogs
12/19/2002WO2002100885A2 A penta- or tetrapeptide binding to somatostatin receptors and the use of the same
12/19/2002WO2002100882A2 Non-endogenous, constitutively activated versions of plant g protein-coupled receptor: gcr1
12/19/2002WO2002100876A1 Dock 3 tumor suppressor gene